HRA005178
Title:
Unraveling the Influence of the Cervical Cancer Tumor Immune Microenvironment on Treatment Response and Prognosis: Insights from Single-Cell Transcriptome Sequencing
Release date:
2023-11-28
Description:
Single-cell transcriptome sequencing was conducted on primary tumors or metastatic lesions from patients diagnosed with cervical cancer, who were undergoing different treatment modalities. The primary objective of this investigation was to explore the biological attributes of the tumors and the composition of the immune microenvironment that could potentially impact treatment effectiveness and prognosis. Ultimately, the study aimed to provide valuable bioinformatic insights to identify a specific subgroup of patients who might derive greater benefits from the treatment.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
cervical cancer
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
TJMUCH RO
Contact person:
Yuan Zhiyong
Email:
zyuan@tmu.edu.cn
Description:
Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital
Individuals & samples
Submitter:   Yuan Zhiyong / zyuan@tmu.edu.cn
Organization:   Tianjin Medical University Cancer Institute & Hospital
Submission date:   2023-07-28
Requests:   3